{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:17Z","timestamp":1792806017552,"version":"4.5.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,2,7]]},"DOI":"10.1001\/jama.2022.24490","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T20:00:38Z","timestamp":1674072038000},"page":"363","source":"Crossref","is-referenced-by-count":48,"title":["Lecanemab Gains FDA Approval for Early Alzheimer Disease"],"prefix":"10.1001","volume":"329","author":[{"given":"Howard D.","family":"Larkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2800770\/jama_larkin_2023_ib_220003_1674761958.2094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T16:05:07Z","timestamp":1675785907000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2800770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,2,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.24490","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}